Article Details
Retrieved on: 2021-06-01 18:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The anti–PD-L1, fully human monoclonal antibody cosibelimab (formerly, CK-301) will be examined in a cohort of patients with metastatic cutaneous ...
Article found on: www.onclive.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here